General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024 | globenewswire.com • |
Acasti to Participate in the H.C. Wainwright Global Investment Conference | globenewswire.com • |
Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting | globenewswire.com • |
Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year? | zacks.com • |
Acasti Pharma Inc. (ACST) Q3 2023 Earnings Call Transcript | seekingalpha.com • |
Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31 | globenewswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-06-28 | 2024-03 | -0.35 | N/A | N/A | N/A |
2024-02-12 | 2023-12 | -0.3 | -0.21 | 0.09 | 30.00% |
2023-11-13 | 2023-09 | -0.29 | -0.19 | 0.1 | 34.48% |
2023-08-11 | 2023-06 | -0.63 | -0.34 | 0.29 | 46.03% |
2023-06-23 | 2023-03 | -0.78 | -0.3 | 0.48 | 61.54% |
2023-02-14 | 2022-12 | -0.78 | -0.54 | 0.24 | 30.77% |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-09-08 | Kohli (Prashant) | Senior Officer of Issuer | 128.14K | Opening Balance-Initial SEDI Report |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Renaissance Technologies, LLC | 11.27K | 35.50K | 0.15% |
2023-06-29 | Geode Capital Management, LLC | 3.06K | 9.63K | 0.04% |
2023-09-29 | National Bank of Canada/FI | 2.90K | 8.07K | 0.04% |
2023-06-29 | Jane Street Group, LLC | 2.37K | 7.46K | 0.03% |
2023-06-29 | Morgan Stanley | 1.88K | 5.93K | 0.03% |
2023-06-29 | Two Sigma Securities, LLC | 2.52K | 7.92K | 0.03% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 3.06K | 9.91K | 0.04% |
Split | Date |
---|---|
1 : 6 | 2023-07-10 |
1 : 8 | 2021-08-31 |
1 : 10 | 2015-10-15 |
1 : 10 | 2015-10-14 |
$ACST great stock. Will see soon
$ACST big surprise on the way
$ACST institutional just jumped in
$ACST remember they would have done a reverse split months ago to regain compliance but they didn’t do so. Patience is a virtue, I still confident something great will come in the nearest time to enhance shareholders value. Why would they risk to get delisted if they still have the easiest alternative of reverse split? Think about it.
@Acastipharma @ACST what is that kind of company? Are they not seeing stock going down? Damn
$ACST mentioned ‘’partnering’’ in their website. We should get PR soon.
$ACST I wish I can add more, could spike hard!
$ACST merger or acquisition very soon. I won’t chase that one, already in 10k shares
$1+ by Friday AH
$ACST don’t chase this one, be there on time. Merger news imminent